Clinical Significance of Heparanase Splice Variant (T5) in Renal Cell Carcinoma: Evaluation by a Novel T5-Specific Monoclonal Antibody

• Uri Barash,

  Affiliation Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel

  ⨯
• Gil Arvatz,

  Affiliation Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel

  ⨯
• Roy Farfara,

  Affiliation Department of Urology, Bnai-Zion Medical Center, Haifa, Israel

  ⨯
• Inna Naroditsky,

  Affiliation Department of Pathology, Rambam Health Care Campus, Haifa, Israel

  ⨯
• Ilana Doweck,

  Affiliation Department of Otolaryngology, Head and Neck Surgery, Carmel Medical Center, Haifa, Israel

  ⨯
• Sari Feld,

  Affiliation Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel

  ⨯
• Ofer Ben-Izhak,

  Affiliation Department of Pathology, Rambam Health Care Campus, Haifa, Israel

  ⨯
• Neta Ilan,

  Affiliation Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel

  ⨯
• Ofer Nativ,

  Affiliation Department of Urology, Bnai-Zion Medical Center, Haifa, Israel

  ⨯
• Israel Vlodavsky

  * E-mail: Vlodavsk@cc.huji.ac.il

  Affiliation Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel

  ⨯